Abvc Biopharma (ABVC) Receivables (2012 - 2024)
Abvc Biopharma's Receivables was $1.21 million in Q3 2024, up 92.7% from $625,903 a year earlier but down 57.6% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Receivables (2012 - 2024) Analysis & Trends
At the end of FY2023, Receivables at Abvc Biopharma came in at $1.59 million, up 4.8% from FY2022.
- Receivables has now increased for three consecutive years, with a five-year compound annual growth rate of 72.9% (FY2018 to FY2023).
- In earlier years, Receivables was $1.51 million in FY2022 (+255.5%), $426,091 in FY2021 (+40.6%), $303,147 in FY2020 (-39.0%) and $497,248 in FY2019 (+384.3%).
- Quarterly Receivables has moved between $47,680 (Q3 2022) and $2.85 million (Q2 2024) over five years.
- Compared with a year earlier, Receivables has increased for three straight quarters, with growth averaging 140.6% over the last seven quarters.
- The best year-over-year quarter for Receivables over five years was Q2 2024 (growth of 428.5%); the worst was Q3 2022 (a decline of 89.9%).
- Per Business Quant data, ABVC's Receivables in the three quarters before Q3 2024 was $2.85 million (Q2 2024), $1.78 million (Q1 2024) and $842,650 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.21 Bn | 1,108.80 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 632.33 Bn | 552.19 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 500.02 Bn | 473.13 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 355.31 Bn | 309.69 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 300.67 Bn | 264.66 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 263.56 Bn | 237.25 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.81 Bn | 193.20 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.42 Bn | 168.61 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Abvc Biopharma | 27.56 Mn | 26.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 842,650.00 |
| Sep 30, 2023 | 625,903.00 |
| Jun 30, 2023 | 538,574.00 |
| Mar 31, 2023 | 644,117.00 |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 47,680.00 |
| Jun 30, 2022 | 431,699.00 |
| Mar 31, 2022 | 426,596.00 |
| Dec 31, 2021 | 426,091.00 |
| Sep 30, 2021 | 473,193.00 |
| Jun 30, 2021 | 442,499.00 |
| Mar 31, 2021 | 1.10 Mn |
| Dec 31, 2020 | 303,147.00 |
| Sep 30, 2020 | 779,232.00 |
| Jun 30, 2020 | 971,232.00 |
| Mar 31, 2020 | 447,995.00 |
| Dec 31, 2019 | 306,844.00 |
API Access
Abvc Biopharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();